In pancreatic cancer, triptolide decreases the expression and activity of O-GlcNAc transferase (OGT), which leads to inhibition of nuclear translocation of Sp1 (Specificity Protein 1) transcription factor. The gene discussed is SP1; the disease is pancreatic neoplasm.